Boehringer Ingelheim develops potential treatment for severe COVID-19 complications
The FINANCIAL -- Boehringer Ingelheim announced the initiation of a Phase 2 clinical trial of BI 764198, an inhibitor of ...
ADVERTISEMENT
Tag: Clinical Trial
ADVERTISEMENT
Popular Last 24h
-
Mexico’s President Sheinbaum Responds to Potential Remittance Tax with Call to “Mobilize”
-
Emlyon business school and Ashoka France form a strategic partnership to train a new generation of entrepreneurs for change
-
Ampersand wins £22m five-year contract at London Zoo
-
Insurers boost private assets allocations as capital increases
-
Iconiq 777 Hosts Pathways to Apprenticeship Awards Ceremony in Newark
-
Three employees killed as Israel attacks Iran’s state TV during live bulletin.
-
Tips for Remodeling on a Budget
LATEST POSTS
LATESTBUSINESS
ADVERTISEMENT
